The health headlines move fast and most coverage gets the science wrong. Every day, Dr. Ravi Kumar, MD, a board-certified neurosurgeon, cuts through the noise: what a new study or story actually says, what it doesn’t, and what it means for you. Researched, sourced, and reviewed before it’s published.
CDC has now linked 6,358 laboratory-confirmed cyclospora infections, 278 hospitalizations and two deaths in Michigan to iceberg lettuce processed by Taylor Farms de Mexico, in what has become the largest cyclosporiasis surge the United States has recorded.
A randomized trial in 1,160 French adults aged 75 and older found that stopping a preventive statin was no worse than continuing it for death rates over three years, even though LDL cholesterol rose by half.
A large prospective trial found scans and blood scores accurate enough to stage liver scarring without a needle, but no test could reliably detect the liver inflammation that determines who qualifies for the new MASH drugs.
The phase 2b ACCESS trial found that aleniglipron, a once-daily oral small-molecule GLP-1 drug, reduced body weight by 9.0% to 12.1% at 36 weeks compared with 0.8% on placebo.
A global review of 23 studies found that hotter days track with more anxiety, depression and emergency visits in children, with the largest jump during heat waves.
A University of Texas at Austin team reports that a wearable focused ultrasound patch shortened the time to REM sleep by 43 minutes and added about 16 minutes of REM in 28 volunteers, though every participant got the fake night first and the real night second.
The CDC has traced 345 Salmonella Javiana infections across 27 states to jalapeno peppers from Sinaloa, Mexico, and whole genome sequencing flagged drug resistance in two of the samples.
A whole-genome study of 24,030 people in 7,851 families found that specific fertility lab procedures, and the age of both parents, track with more brand new mutations in a child's DNA.
The American Red Cross declared only the second national blood supply crisis in its history on July 27, 2026, and surgeons are being told the shortage could delay operations.
A new Nature Medicine audit ran 810 multi-turn conversations against nine frontier chatbots and found the biggest danger was not bad advice, it was agreement.
A meta-analysis of 14 randomized trials and 4,174 patients found that clot busting drugs given 4.5 hours or more after stroke onset improved 90-day recovery, at the cost of a much higher rate of symptomatic bleeding into the brain.
The ICECAP trial cooled 1,158 comatose cardiac arrest survivors for anywhere from 6 to 72 hours and found that the longer durations did not improve brain recovery at 90 days.